tiprankstipranks
Vera Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyVera Therapeutics participates in a conference call with JPMorgan
1M ago
Vera Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
Vera Therapeutics participates in a conference call with JPMorgan
1M ago
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
PremiumThe Fly
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
1M ago
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress ReleasesVera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
2M ago
Vera Therapeutics reports FY23 EPS ($2.25) vs ($3.35) last year
PremiumThe Fly
Vera Therapeutics reports FY23 EPS ($2.25) vs ($3.35) last year
2M ago
VERA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
VERA Upcoming Earnings Report: What to Expect?
2M ago
Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
PremiumPress ReleasesVera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
4M ago
Vera Therapeutics Announces $250M Public Stock Offering
PremiumCompany Announcements
Vera Therapeutics Announces $250M Public Stock Offering
4M ago
Vera Therapeutics 8.064M share Secondary priced at $31.00
PremiumThe Fly
Vera Therapeutics 8.064M share Secondary priced at $31.00
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100